.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Chronic Health is stocked at 43 licensed dispensaries across Arizona, with the deepest coverage in Phoenix, Mesa, Tucson, El Mirage, and Kingman. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Chronic Health’s mix concentrated in Topical at 62.68% share while Tincture & Sublingual held 37.33%, with Topical down 14.10% year over year and 20.27% month over month versus Tincture & Sublingual down 19.36% year over year and 7.25% month over month. Despite an average price decline of 3.47% year over year to $18.03, Topical’s sharper month-over-month contraction indicates near-term elasticity limits, whereas Tincture & Sublingual’s smaller month-over-month dip suggests steadier unit pull; the pattern implies portfolio dependence on Topical is amplifying monthly volatility even as both categories retrench year over year.
With Topical anchored at rank 2 in the category in Arizona, the 20.27% month-over-month Topical decline combined with a milder 7.25% month-over-month slide in Tincture & Sublingual implies Chronic Health’s current positioning is tied to a leading but more momentum-sensitive pillar. The 14.10% year-over-year Topical drop versus the 19.36% year-over-year decline in Tincture & Sublingual indicates brand equity is stronger in Topical than in Tincture & Sublingual, yet the heavier 62.68% Topical mix magnifies exposure to monthly swings; strategically, this points to reallocating mix toward the relatively steadier Tincture & Sublingual to moderate volatility while defending the Topical rank 2 beachhead.
Competitive Landscape
Chronic Health is ranked #2 in AZ Topical in August 2026, unchanged from #2 year over year, after peaking at #1 in March 2025; this static #2 position alongside a 0-rank change over three months indicates stable placement but limited upward momentum. In contrast, Drip Oils + Extracts holds #1 both currently and year over year while growing sales 50.8%, and Gramz climbed from #7 to #3 with 103.8% sales growth, outpacing the category’s middle tier as iLava slipped from #3 to #4 with a 27.5% sales decline. The pattern implies that Chronic Health’s flat rank and proximity to faster-rising rivals increase the risk of displacement unless share-accretive moves recover the March 2025 peak trajectory.
Notable Products
CBD High Ointment (350mg CBD, 2oz) posted the largest month-over-month gain at 96.9% and climbed to rank 6, while Indica THC Glycerin Tincture (100mg THC, 1oz) fell 33.9% to rank 3, signaling a pivot away from THC-only formats toward higher-CBD topicals. Tincture & Sublingual holds ranks 1-3, but two of those SKUs declined, with CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz) down 7.3% at rank 2 as CBD/THC 1:1 Glycerin Tincture (100mg CBD, 100mg THC, 1oz) rose 24.7% at rank 1, implying intra-category share is consolidating around balanced 1:1 formulas. Four of the top ten are Topical SKUs, yet within that group the 4oz CBD/THC 1:1 Pain Relief Ointment dropped 24.1% at rank 5 while the 50mg CBD/THC 1:1 Pain Relief Ointment slid 21.8% at rank 9 as the Roll-On grew 20.2% at rank 8, indicating format convenience is offsetting potency-tier softness. Taken together, August 2026 mix points to Chronic Health leaning into CBD-forward relief and convenient delivery over larger-size or THC-only options, with one standout value SKU driving dollar growth to $7,982 in the 175mg 1:1 ointment but momentum shifting toward lighter, approachable topicals.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
